|Articles|September 1, 2003

Phase IV filgrastim study shows drug lives up to expectations

Amgen's filgrastim delivers what it promises in a phase IV study

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME